Recommended

Amgen secures Uplizna EU approval in gMG
Orsellinic acid study demonstrates production first
WEBINAR | Harnessing AI for more efficient clinical trials | REGISTER TODAY
J&J to site new $1bn cell therapy facility in Pennsylvania
FDA sets new default standard for US drug approvals
Daiichi Sankyo picks new Global Head of R&D
Dr Belén Garijo replaces Paul Hudson as Sanofi CEO
Discover how to harness digital PCR for rapid sterility testing
webinar

How to master raw material ID testing in 2021

Supported by:

9 December 2020

Watch now
6
SHARES

Supported by:

9 December 2020

Watch now

Thermo Fisher Scientific

ABOUT THIS  ON-DEMAND WEBINAR

Now, more than ever, the assurance that therapeutic and preventative drugs have gone through rigorous and regulated quality control is a primary driver of patient trust in personalised medicines and vaccines. The nature of the pharmaceutical industry is transforming to focus more on biologic drug products and parenteral treatments manufactured in cGMP environments vastly different from traditional oral tablets or capsules. Despite these industry changes, the identification of APIs, excipients and cell culture medias for drug manufacturing and the identification of drug substances remains a constant need, not to mention the importance of brand protection against counterfeits.

 

SPACES ARE FILLING FAST – SECURE YOURS!


Rapid sterility testing is no longer optional for advanced therapies – it’s becoming operationally essential. Join this webinar to explore rapid sterility testing methods that ensure fast, reliable product release, addressing critical challenges in timely delivery and safety.

Harnessing digital PCR for rapid sterility testing

18 March 2026 | 3PM

What you’ll discover:

  • Rapid sterility testing methods that address the challenge of lengthy testing times, improving efficiency and ensuring timely product release
  • Insights into how digital PCR technology enhances testing accuracy and sensitivity, detecting contaminants quickly and reliably
  • Real-world case studies on rapid testing implementations in the field of cell and gene therapy

The session will discuss future trends in sterility testing and showcase successful rapid sterility testing in cell and gene therapy products, demonstrating practical applications and benefits.

Register now to join live or for free access to the on-demand recording if you can’t make the date

In this on-demand webinar we explore the evolving role of handheld and portable instruments to drive quality improvements and manufacturing success in 2021.

Key learning outcomes:

  • Understand why chemically defined cell culture medias are trending and how to differentiate between similar medias
  • Examine new opportunities to test ionic salts and close the gap towards 100 percent raw material identification
  • Explore time and productivity savings observed by performing quantitative analysis using handheld spectroscopy
  • See how real-time release testing can be accomplished and achieve drug substance and drug product identification.

Register

Register to watch this on-demand webinar

    Unless making a secure payment with your credit or debit card via a third-party payment processor, this form is not designed to collect confidential or sensitive personal information (e.g., financial information, social security numbers).

    *Required field

    Your details


    *


    *


    *


    *


    *



    *

    Other information

    Email preferences

    If you’re not already opted-in to receive our emails, please select which types of communication you would like to receive:


    Confirm that you're human

    By clicking register, you consent to European Pharmaceutical Review contacting you about this and future webinars, and that you agree to our terms and conditions and privacy policy. Your information will be processed in accordance with GDPR and you can unsubscribe at any time.

    Speakers

    Dean Stuart, Product Manager, Thermo Fisher Scientific  

    Dean Stuart Dean Stuart is a Product Manager for Thermo Fisher Scientific passionate about the advancement of scientific instrumentation. Throughout his career, Dean has shown a special interest in sustainable quality improvements for the pharmaceutical industry. His prior roles include a quality control scientist and an analytical methods developer at Boehringer Ingelheim. Dean currently specialises in the development of portable Raman, Near Infrared Spectroscopy (NIR) and X-ray Fluorescence (XRF) technologies for the biopharmaceutical industry.

    Eden Couillard, Scientist III, Thermo Fisher Scientific 

    Eden CouillardEden Couillard is a Scientist for Thermo Fisher Scientific working to develop the latest portable scientific instrumentation. During her time at Thermo Fisher, Eden has worked as a technical lead and aided in the creation of several new products including the Thermo Scientific™ IonicX portable XRF analyser. Her prior roles include a synthetic research chemist for Johnson Matthey Pharma Services. Currently, Eden specialises in portable Raman, Fourier Transform Infrared Spectroscopy (FTIR), and X-ray Fluorescence (XRF) technologies.

     
    Share via
    Share via